Background and Purpose The most common strategy for treating patients with acute
ischemic stroke is thrombolytic therapy, though only a few patients receive benefits because …

The number of circulating monocytes increases after stroke. In this study, we assessed the
time course and phenotype of monocyte subsets and their relationship with the clinical …

Background and Purpose—Monocytes participate in adaptive and innate immune
responses. Monocyte numbers increase in patients with stroke associated infection (SAI) or …

Aims Ischemic stroke is one of the leading causes of death worldwide and the most common
cause of disability in Western countries. Multiple mechanisms contribute to the development …

Ischemic stroke accounts for the majority of stroke cases and constitutes a major cause of
death and disability in the industrialized world. Inflammation has been reported to constitute …

Ischaemic stroke elicits a strong neuroinflammatory response, but the functional relevance
and therapeutic potential of neuroinflammation has only recently become apparent. In acute …

Introduction: Circulating neutrophil and lymphocyte levels may be modifiable outcome
predictors of ischemic stroke. We sought to compare these immune cell parameters with …

The immune response to stroke is an exciting target for future stroke therapies. Stroke is a
leading cause of morbidity and mortality worldwide, and clot removal (mechanical or …

Background The immune response to acute ischemic stroke (AIS) is implicated in diagnosis,
prognosis, and intervention; however, the temporal dynamics of leukocytes following AIS are …

The inflammatory response is an unavoidable process and contributes to the destruction of
cerebral tissue during the acute ischemic stroke (AIS) phase and has not been addressed …